Presentation TCT 2016 Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Bernard J. Gersh October 30, 2016 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2016 Up Next Presentation TCT 2016 Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry Presenter: Neil E. Moat October 30, 2016 More slides + Presentation TCT 2016 Mediation Analysis: A Method to Assign Attributable Risk Presenter: Bjorn Redfors October 30, 2016 Presentation TCT 2016 What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant! Presenter: Nir Uriel October 30, 2016 We Recommend
Presentation TCT 2016 Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry Presenter: Neil E. Moat October 30, 2016
Presentation TCT 2016 Mediation Analysis: A Method to Assign Attributable Risk Presenter: Bjorn Redfors October 30, 2016
Presentation TCT 2016 What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant! Presenter: Nir Uriel October 30, 2016